Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann Gils

Showing results (121-130 of 162) with videos related to

Pageof 17
Sort By:
Molecular Pharmacology|June 19, 2008
A peptide accelerating the conversion of plasminogen activator inhibitor-1 to an inactive latent stateLisa Mathiasen, Daniel M Dupont, Anni Christensen, et al.
Journal of Crohn'S & Colitis|September 11, 2019
Influence of Drug Exposure on Vedolizumab-Induced Endoscopic Remission in Anti-Tumour Necrosis Factor [TNF] Naïve and Anti-TNF Exposed IBD PatientsBram Verstockt, Evelien Mertens, Erwin Dreesen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 6, 2003
Development of a genotype 325-specific proCPU/TAFI ELISAAnn Gils, Marie-Christine Alessi, Els Brouwers, et al.
Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)|February 9, 2019
Predicting iron absorption from an effervescent iron supplement in obese patients before and after Roux-en-Y gastric bypass: a preliminary studyIna Gesquiere, Nele Steenackers, Matthias Lannoo, et al.
Journal of Clinical Gastroenterology|December 3, 2019
Successful Infliximab Treatment is Associated With Reversal of Clotting Abnormalities in Inflammatory Bowel Disease PatientsIris Detrez, Debby Thomas, Kristel Van Steen, et al.
Gut|April 17, 2015
Immunogenicity to infliximab is associated with HLA-DRB1Thomas Billiet, Niels Vande Casteele, Thomas Van Stappen, et al.
Blood|December 26, 2014
Innovative thrombolytic strategy using a heterodimer diabody against TAFI and PAI-1 in mouse models of thrombosis and strokeTine Wyseure, Marina Rubio, Frederik Denorme, et al.
United European Gastroenterology Journal|July 19, 2019
Early vedolizumab trough levels predict combined endoscopic and clinical remission in inflammatory bowel diseaseJurij Hanžel, Nejc Sever, Ivan Ferkolj, et al.
Thrombosis and Haemostasis|January 30, 2018
A Genome-wide Study of Common and Rare Genetic Variants Associated with Circulating Thrombin Activatable Fibrinolysis InhibitorTara M Stanne, Maja Olsson, Erik Lorentzen, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 23, 2016
Generation and characterization of a unique panel of anti-adalimumab specific antibodies and their application in therapeutic drug monitoring assaysSumin Bian, Thomas Van Stappen, Filip Baert, et al.
Pageof 17

Showing results (121-130 of 162) with videos related to

Sort By:
Pageof 17
Molecular Pharmacology|June 19, 2008
A peptide accelerating the conversion of plasminogen activator inhibitor-1 to an inactive latent stateLisa Mathiasen, Daniel M Dupont, Anni Christensen, et al.
Journal of Crohn'S & Colitis|September 11, 2019
Influence of Drug Exposure on Vedolizumab-Induced Endoscopic Remission in Anti-Tumour Necrosis Factor [TNF] Naïve and Anti-TNF Exposed IBD PatientsBram Verstockt, Evelien Mertens, Erwin Dreesen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 6, 2003
Development of a genotype 325-specific proCPU/TAFI ELISAAnn Gils, Marie-Christine Alessi, Els Brouwers, et al.
Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)|February 9, 2019
Predicting iron absorption from an effervescent iron supplement in obese patients before and after Roux-en-Y gastric bypass: a preliminary studyIna Gesquiere, Nele Steenackers, Matthias Lannoo, et al.
Journal of Clinical Gastroenterology|December 3, 2019
Successful Infliximab Treatment is Associated With Reversal of Clotting Abnormalities in Inflammatory Bowel Disease PatientsIris Detrez, Debby Thomas, Kristel Van Steen, et al.
Gut|April 17, 2015
Immunogenicity to infliximab is associated with HLA-DRB1Thomas Billiet, Niels Vande Casteele, Thomas Van Stappen, et al.
Blood|December 26, 2014
Innovative thrombolytic strategy using a heterodimer diabody against TAFI and PAI-1 in mouse models of thrombosis and strokeTine Wyseure, Marina Rubio, Frederik Denorme, et al.
United European Gastroenterology Journal|July 19, 2019
Early vedolizumab trough levels predict combined endoscopic and clinical remission in inflammatory bowel diseaseJurij Hanžel, Nejc Sever, Ivan Ferkolj, et al.
Thrombosis and Haemostasis|January 30, 2018
A Genome-wide Study of Common and Rare Genetic Variants Associated with Circulating Thrombin Activatable Fibrinolysis InhibitorTara M Stanne, Maja Olsson, Erik Lorentzen, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 23, 2016
Generation and characterization of a unique panel of anti-adalimumab specific antibodies and their application in therapeutic drug monitoring assaysSumin Bian, Thomas Van Stappen, Filip Baert, et al.
Pageof 17